Blog
Sustainability Through Innovation
BlogWith growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Read More
From Growing Cells to Growing a Business
BlogHow do you start, grow and run a successful life science company? To find out we spoke to Dr Yichen Shi, CEO of Axol Bioscience.
Read More
Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
BlogDuring this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.
Read More
Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis
BlogTo learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.
Read More
The STING Pathway and Cancer
BlogSTING (stimulator of interferon genes) is a key mediator of innate immunity and the STING pathway has been shown to be involved in the induction of an anti-tumor immune response. We recently spoke to Andrea van Elsas, PhD, Chief Scientific Officer at Aduro Biotech to learn more about the company’s expertise in STING Pathway Activator technology.
Read More
HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR
BlogDuring this year’s AACR Annual Meeting we spoke to Julianna Supplee, Research Technician at the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to learn more about the team’s most recent study on the use of plasma HPV cell-free DNA as an early predictor of treatment response in patients with advanced oropharyngeal cancer.
Read More
Using Cell-free DNA as a Marker for Liver Cancer Diagnosis
BlogDuring this year’s AACR conference we spoke to Kang Zhang, M.D., Ph.D. from the University of California, San Diego about the collaborative work he has been doing with the Laboratory for Advanced Medicine. He discusses their recent study findings on the use of a blood-based method to look at cell-free DNA as a marker for liver cancer diagnosis and prognosis.
Read More
Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment
BlogWe recently spoke to Gaurav Singal, Vice President of Data Strategy and Product Development at Foundation Medicine, to learn more about how their SmartTrialsTM technology platform has enabled patients to be rapidly matched to precision trials, based on their unique tumor biomarkers.
Read More
Accelerating the Development of Organs-on-Chips
BlogEmulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.
Read More
Deploying Cloud Technologies to Fight Pediatric Cancer
BlogThe St. Jude Cloud is a recently-launched online data-sharing and collaboration platform that provides access to the largest public repository of pediatric cancer genomics data. We caught up with Jinghui Zhang, PhD, from St. Jude Children’s Research Hospital to discuss the cloud and its impact on pediatric research.
Read More
